Skip to main content

Select Drug Profiles

No Outcome, No Income

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Accountability Is Everything: Outcomes-Based Pharmaceutical Agreements

Javier Gonzalez, PharmD

Javier González, PharmD

Original Research, Cardiometabolic Health

Employer-Sponsored Wellness Programs for Hypertension and Dyslipidemia in a 2-Hospital Health System

Anne Misher, PharmD, BCACP, BC-ADM, CDE, Jessica Brown, PharmD, Christina Maguire, PharmD, Alix P. Schnibben, PharmD, BCACP, CTTS

Anne Misher, PharmD, BCACP, BC-ADM, CDE; Jessica Brown, PharmD; Christina Maguire, PharmD; Alix P. Schnibben, PharmD, BCACP, CTTS

Stakeholder Perspective

Benefits of Employer-Sponsored Wellness Programs for Chronic Diseases

F. Randy Vogenberg, RPh, PhD, FASHP

by F. Randy Vogenberg, PhD, FASHP

FDA on In Vitro Diagnostics, Vaping; Cost of Novel Treatments

FDA Approvals, Multiple Myeloma, In the News, Oncology

FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma

The Healthcare Start-Up Nation

David B. Nash, MD, MBA

David B. Nash, MD, MBA

The Challenge of High Drug Prices in America: Cost Disclosure in Direct-to-Consumer Advertising May Offer a Solution

Kamille Garness, MD, MPH Candidate

Kamille Garness, MD, MPH Candidate

Original Research, Pain, Cardiometabolic Health

Dipeptidyl Peptidase-4 Inhibitors and Joint Pain: A Retrospective Cohort Study of Older Veterans with Type 2 Diabetes Mellitus

Pragya Rai, MS, Nilanjana Dwibedi, BPharm, MBA, PhD, Mazhgan Rowneki, MPH, Drew A. Helmer, MD, MS, Usha Sambamoorthi, PhD

Pragya Rai, MS; Nilanjana Dwibedi, PhD; Mazhgan Rowneki, MPH; Drew A. Helmer, MD, MS; Usha Sambamoorthi, PhD

Stakeholder Perspective

Impact of DPP-4 Inhibitors on Joint Pain in Older Veterans with Diabetes

Priya Nileshwar, DO; Quang Nguyen, DO, FACE, FTOS

by Priya Nileshwar, DO, Quang T. Nguyen, DO, FACE, FTOS

Practice Management

Value-Based Agreements in Healthcare: Willingness versus Ability

Gary Branning, MBA, Michael Lynch, CPA, MBA, Kathryn Hayes, BA

Gary Branning, MBA; Michael Lynch, CPA, MBA; Kathryn Hayes

Review Article, Practice Management

Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present

Cori Gray, PharmD, Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM, Nicole Brandt, PharmD, MBA, BCPP, BCGP, FASCP

Cori Gray, PharmD; Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM; Nicole Brandt, PharmD, MBA, BCPP, BCGP, FASCP

Stakeholder Perspective

Successes and Challenges of the Medicare Part D MTM Program

Jack E. Fincham, PhD, RPh

by Jack E. Fincham, PhD, RPh

Page 45 of 244
Results 441 - 450 of 2434